Contributors

  • Andrew Ramonas
    Lobbying Reporter
  • Beth Frerking
    Editor in Chief
  • David Brown
    Vice President/Editor, ALM
  • Diego Radzinschi
    Photo Editor
  • Jenna Greene
    Senior Reporter
  • Marcia Coyle
    Chief Washington Correspondent
  • Mike Scarcella
    Washington Bureau Chief
  • Todd Ruger
    Capitol Hill Reporter
  • Tony Mauro
    Supreme Court Correspondent
  • Zoe Tillman
    D.C. Courts Reporter

« Steptoe Lobbying for Natural Gas Group on Energy and Tax Legislation | Main | The Morning Wrap »

October 02, 2012

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83451d94869e2017d3c7625e3970c

Listed below are links to weblogs that reference Judge Hits Abbott Laboratories with $700M in Fines for Off-Label Drug Marketing:

Comments

Lindy Lou

who really pays when a drug company like this gets fined? does the price of their medications go up, ya think?

I'm quite sure everyone there still gets the same pay, and the investors still get their returns. The patients who take their drugs end up paying.

Lulaine

Many companies are hit with these charges that say they were doing the wrong kind of marketing or marketing their product that had issues. Companies have to be very careful because certain marketing methods can actually increase their liability especially if the product has some problems.

The comments to this entry are closed.

Blog powered by Typepad

Advertisements